Kinematic assay of plasma glucose concentration without blood sampling
First Claim
Patent Images
1. A method for the determination of an in vivo glucose concentration without blood sampling comprising the steps of:
- (a) directing a beam of light to a body part of a patient;
(b) administering a hypoglycemic drug to the patient to impose a kinematic perturbation in the in vivo glucose concentration;
(c) identifying an optical absorption band of in vivo glucose measuring an intensity of a glucose signal;
(d) measuring a rate of decrease of the intensity of the glucose signal with time;
(e) determining an original glucose signal from the rate of decrease measured and(f) converting the original signal into an original in glucose concentration.
1 Assignment
0 Petitions
Accused Products
Abstract
A method is described which can identify the plasma glucose optical signal from the high background in a "total finger spectrum" by causing changes in the signal upon altering glucose concentration by administering a glucose-specific drug such as insulin, and also determine the original concentration by measuring the rate of the change as a first order kinetic dependent on the initial concentration.
48 Citations
13 Claims
-
1. A method for the determination of an in vivo glucose concentration without blood sampling comprising the steps of:
-
(a) directing a beam of light to a body part of a patient; (b) administering a hypoglycemic drug to the patient to impose a kinematic perturbation in the in vivo glucose concentration; (c) identifying an optical absorption band of in vivo glucose measuring an intensity of a glucose signal; (d) measuring a rate of decrease of the intensity of the glucose signal with time; (e) determining an original glucose signal from the rate of decrease measured and (f) converting the original signal into an original in glucose concentration. - View Dependent Claims (2)
-
-
3. A method for identifying instrumental signals associated with in situ cellular components and measuring in vivo a concentration of the components comprising the steps of:
-
(a) administering to a patient a compound specific for the component to be measured, wherein the compound imposes a kinematic perturbation which changes the in vivo concentration of the component specific for the component to be measured; (b) measuring a rate of change of the in vivo concentration of the component; (c) and determining the original in vivo concentration of the component from the rate of change measured.
-
-
4. A method for determining in vivo glucose concentrations without blood sampling comprising the steps of:
-
(a) detecting an intensity of glucose signals non invasively by projecting energy through a body part of a patient and detecting energy received through the body part; (b) administering a hypoglycemic drug to the patient (c) sequentially detecting changes in the intensity of the glucose signals; (d) measuring a rate of changing intensity of the sequentially detected glucose signals; and (e) determining an original glucose concentration from the measured rate of changing intensity. - View Dependent Claims (5)
-
-
6. A method for the determination of in vivo glucose concentrations without blood sampling comprising the steps of:
-
(a) administering a hypoglycemic drug to a patient; (b) projecting light through a body part of the patient, measuring a decreasing optical spectrum at subsequent time intervals to obtain difference spectra, and identifying a peak absorbance position of the in vivo glucose from the difference spectra corresponding to the decreasing glucose concentration; (c) plotting changing peak absorbances on a logarithmic axis versus time on a linear abscissa (semi-log plot) to obtain a straight line; (d) interpolating the straight line with a negative slope to the axis logarithmic at time zero for obtaining an original pure glucose absorbance; (e) comparing the original glucose absorbance against a reference table comprising a column of original glucose absorbance values matched with pre-determined blood glucose concentrations determined by a blood sampling method before administration of the hypoglycemic drug; (f) and determining the original glucose concentration from the comparing step. - View Dependent Claims (7, 8)
-
-
9. A method for identifying instrumental signals in in-vivo cellular components and measuring an in vivo concentration of the components comprising the steps of:
-
(a) administering a compound to a patient specific for a component to be measured that causes changes in the in vivo concentration of the component; (b) projecting energy through a body part of the patient and detecting energy received through the body part to measure differential changes in intensity of a spectrum over a time period to obtain an identity of a peak position of the component; (c) plotting the changes in intensity of the peak position on an appropriate scale in a semi-log plot to obtain a line; (d) interpolating the obtained line to an original intensity at a time before the administering of the compound to obtain an original pure component intensity; (e) matching the so obtained original pure component intensity against a reference table constructed by collection of data obtained by measuring concentration through blood sampling before administration of the compound.
-
-
10. A method for determining in vivo glucose concentrations comprising the steps of:
-
(a) identifying a glucose signal by administration of a hypoglycemic drug, finding a changing intensity signal and interpreting the changing intensity signal as a decreasing glucose signal; (b) obtaining a first order kinetic analysis of the decreasing glucose signal to obtain a kinetic constant from a slope of a semi-log plot for storing in a database for a diagnostic purpose.
-
-
11. A method for identifying in vivo glucose signals blood sampling comprising the steps of:
-
(a) administering a hypoglycemic drug to a patient; (b) obtaining with respect to a time a changing glucose signal to identify a pure glucose spectrum and its peak intensity; (c) plotting the changing peak intensity on an appropriate plot in a first order or semi-log kinetic plot; (d) interpolating a straight line to an origin at time zero to obtain an original in vivo blood plasma glucose concentration. - View Dependent Claims (12, 13)
-
Specification